Carbohydrate-based anti-inflammatories - Praxis/Fairchild
Latest Information Update: 13 Dec 2023
At a glance
- Originator Anutech
- Developer Anutech; Praxis Pharmaceuticals
- Class Carbohydrates
- Mechanism of Action Insulin-like growth factor II stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ocular inflammation; Post-surgical adhesions; Psoriasis; Rheumatoid arthritis; Skin aging